MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Conjugal Parkinsonism

    CK. Tan (Singapore, Singapore)

    Objective: To report a case of multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) in a couple. Background: Conjugal parkinsonism denotes an entity where…
  • 2025 International Congress

    Atypical Parkinsonism with LRRK2 Mutation Presenting as Multiple System Atrophy

    K. Makhoul, R. Ramdhani (Great neck, USA)

    Objective: We describe a rare case of atypical parkinsonism associated with leucine-rich repeat kinase 2 (LRRK2) gene mutation presenting with clinical features suggestive of multiple…
  • 2025 International Congress

    A Randomized, Double-blind Phase 3 Trial of Amlenetug Versus Placebo in Patients with MSA: The MASCOT Trial

    L. Kjærsgaard, M. Nørbæk Jørgensen, S. Zanigni, J. Wiedemann, J. Luthman (Valby, Denmark)

    Objective: Describe the protocol for a randomized, double-blind phase 3 trial evaluating the efficacy and safety of amlenetug versus placebo in slowing clinical progression in…
  • 2025 International Congress

    Dopa-Responsive Parkinsonism Secondary to Tauopathy: Clinical, Pathological, and Genetic Study

    S. Giri Ravindran, B. Daud Shah, E. Noyes, V. Zherebitskiy, A. Rajput, M. Farrer, A. Rajput (Saskatoon, Canada)

    Objective: To report on the clinical, pathological, and genetic findings of four cases of levodopa-responsive parkinsonism with long survival and tauopathy. Background: The most common…
  • 2025 International Congress

    Oxidative stress in Progressive Supranuclear Palsy

    P. Alster, D. Otto-ślusarczyk, M. Struga, N. Madetko-Alster (Warsaw, Poland)

    Objective: The goal of the study is to evaluate the significance of oxidative stress in the examination and pathophysiology of Progressive Supranuclear Palsy (PSP). Additionally,…
  • 2025 International Congress

    Neurologic Music Therapy and Non-Invasive Brain Stimulation for Upper Extremity Performance in Patients with Corticobasal Syndrome

    K. Kang, I. Sterner, S. Bakhshi, C. Bedell, A. Pantelyat (Baltimore, USA)

    Objective: To explore the effects of Neurologic Music Therapy (NMT) with or without non-invasive brain stimulation on upper limb performance in patients with corticobasal syndrome…
  • 2025 International Congress

    Simple linear measurements of the putamen reliably differentiate MSA from other parkinsonian disorders on MRI.

    T. Rohringer, V. Lam Shin-Cheung, P. Alcaide-Leon (Toronto, Canada)

    Objective: This study evaluates the utility of simple linear measurements of the putamen to distinguish Multiple System Atrophy (MSA) from idiopathic Parkinson’s Disease (iPD) and…
  • 2025 International Congress

    Neuroprotective efficacy of EDTA against manganese neurotoxicity: Implications for modulating Parkinsonian syndromes

    H. Harifi, H. Hami, L. Bikjdaouene (Kenitra, Morocco)

    Objective: This study investigates the neuroprotective potential of ethylenediaminetetraacetic acid (EDTA) in reducing the neurotoxic effects of manganese (Mn), focusing on both motor and non-motor…
  • 2025 International Congress

    Clinical and Dopaminergic Characteristics of MSA-C Patients with Predominant Cerebellar Asymmetry

    DG. Park, YS. Kim, YS. An, JH. Yoon (Suwon, Republic of Korea)

    Objective: To identify multiple system atrophy–cerebellar type (MSA-C) patients with marked cerebellar asymmetry and compare their features with symmetrically affected patients. Background: While asymmetry is…
  • 2025 International Congress

    Normal Pressure Hydrocephalus in Vestibular Schwannoma Patients

    T. Davidy, S. Anis, T. Goldberg, A. Fay-Karmon, Y. Zauberman, N. Rennert, O. Lesman-Segev, S. Hassin-Baer (Cleveland, USA)

    Objective: The first objective is to evaluate the potential pathophysiological link between vestibular schwannoma (VS) and normal pressure hydrocephalus (NPH) by analyzing clinical features, imaging…
  • « Previous Page
  • 1
  • …
  • 88
  • 89
  • 90
  • 91
  • 92
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley